5-132486380-A-G

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_002198.3(IRF1):​c.545-7T>C variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.345 in 1,610,364 control chromosomes in the GnomAD database, including 97,385 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.38 ( 11305 hom., cov: 33)
Exomes 𝑓: 0.34 ( 86080 hom. )

Consequence

IRF1
NM_002198.3 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.00001620
2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.132
Variant links:
Genes affected
IRF1 (HGNC:6116): (interferon regulatory factor 1) The protein encoded by this gene is a transcriptional regulator and tumor suppressor, serving as an activator of genes involved in both innate and acquired immune responses. The encoded protein activates the transcription of genes involved in the body's response to viruses and bacteria, playing a role in cell proliferation, apoptosis, the immune response, and DNA damage response. This protein represses the transcription of several other genes. As a tumor suppressor, it both suppresses tumor cell growth and stimulates an immune response against tumor cells. Defects in this gene have been associated with gastric cancer, myelogenous leukemia, and lung cancer. [provided by RefSeq, Aug 2017]
IRF1-AS1 (HGNC:33838): (colitis associated IRF1 antisense regulator of intestinal homeostasis)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 5-132486380-A-G is Benign according to our data. Variant chr5-132486380-A-G is described in ClinVar as [Benign]. Clinvar id is 2688381.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.481 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
IRF1NM_002198.3 linkuse as main transcriptc.545-7T>C splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000245414.9 NP_002189.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
IRF1ENST00000245414.9 linkuse as main transcriptc.545-7T>C splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_002198.3 ENSP00000245414 P1
IRF1-AS1ENST00000612967.2 linkuse as main transcriptn.469A>G non_coding_transcript_exon_variant 4/41

Frequencies

GnomAD3 genomes
AF:
0.379
AC:
57575
AN:
151940
Hom.:
11291
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.487
Gnomad AMI
AF:
0.228
Gnomad AMR
AF:
0.343
Gnomad ASJ
AF:
0.323
Gnomad EAS
AF:
0.362
Gnomad SAS
AF:
0.409
Gnomad FIN
AF:
0.329
Gnomad MID
AF:
0.491
Gnomad NFE
AF:
0.333
Gnomad OTH
AF:
0.361
GnomAD3 exomes
AF:
0.348
AC:
86678
AN:
248886
Hom.:
15309
AF XY:
0.348
AC XY:
46862
AN XY:
134780
show subpopulations
Gnomad AFR exome
AF:
0.486
Gnomad AMR exome
AF:
0.327
Gnomad ASJ exome
AF:
0.317
Gnomad EAS exome
AF:
0.345
Gnomad SAS exome
AF:
0.391
Gnomad FIN exome
AF:
0.325
Gnomad NFE exome
AF:
0.330
Gnomad OTH exome
AF:
0.357
GnomAD4 exome
AF:
0.341
AC:
497694
AN:
1458306
Hom.:
86080
Cov.:
40
AF XY:
0.342
AC XY:
248129
AN XY:
725544
show subpopulations
Gnomad4 AFR exome
AF:
0.491
Gnomad4 AMR exome
AF:
0.331
Gnomad4 ASJ exome
AF:
0.316
Gnomad4 EAS exome
AF:
0.331
Gnomad4 SAS exome
AF:
0.387
Gnomad4 FIN exome
AF:
0.327
Gnomad4 NFE exome
AF:
0.335
Gnomad4 OTH exome
AF:
0.349
GnomAD4 genome
AF:
0.379
AC:
57632
AN:
152058
Hom.:
11305
Cov.:
33
AF XY:
0.378
AC XY:
28112
AN XY:
74338
show subpopulations
Gnomad4 AFR
AF:
0.487
Gnomad4 AMR
AF:
0.343
Gnomad4 ASJ
AF:
0.323
Gnomad4 EAS
AF:
0.361
Gnomad4 SAS
AF:
0.410
Gnomad4 FIN
AF:
0.329
Gnomad4 NFE
AF:
0.333
Gnomad4 OTH
AF:
0.361
Alfa
AF:
0.346
Hom.:
2696
Bravo
AF:
0.382
Asia WGS
AF:
0.377
AC:
1312
AN:
3478
EpiCase
AF:
0.329
EpiControl
AF:
0.325

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJan 24, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 66% of patients studied by a panel of primary immunodeficiencies. Number of patients: 58. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
5.7
DANN
Benign
0.45
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000016
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2070724; hg19: chr5-131822072; COSMIC: COSV55377468; COSMIC: COSV55377468; API